Login / Signup

Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

Nabih MaslahSalome RetyMelina BonnamyLorea AguinagaTony HuynhVeronique PariettiStephane GiraudierPierre FenauxBruno Cassinat
Published in: Leukemia (2024)
Keyphrases